Quick Answer
ATOSSA THERAPEUTICS, INC. reported Gross Profit of -$130.7 thousand for the year ending 2015.
- ATOSSA THERAPEUTICS, INC. showed a decrease of -425.5% in Gross Profit from 2014 to 2015.
- This data is from ATOSSA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 16, 2017.
- XBRL data for this metric is available from 2011 to 2015 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2012: $27.7 thousand | Q2 2012: $205.3 thousand | Q3 2012: $90.5 thousand | Q1 2013: $116.2 thousand | Q2 2013: $103.9 thousand | Q3 2013: $50.7 thousand | Q1 2014: $24.1 thousand | Q2 2014: $9.9 thousand | Q3 2014: $3.4 thousand | Q1 2015: $0.00 | Q2 2015: $0.00 | Q3 2015: $458.8 thousand | Q1 2016: $0.00 | Q2 2016: $0.00.
- Over the full 5 years of available data (2011 to 2015), ATOSSA THERAPEUTICS, INC.'s Gross Profit has declined by 36.5%.
- Historical annual values: Fiscal year 2015: -$130.7 thousand | Fiscal year 2014: $40.1 thousand | Fiscal year 2013: $137.1 thousand | Fiscal year 2012: $416.2 thousand | Fiscal year 2011: -$95.7 thousand.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: